Healthcare_medical .

Login now to join in the fun!

latest updates

  • Capnography Equipment Market worth $436 million by 2027 https://www.marketsandmarkets.com/Market-Reports/capnography-equipment-market-236876330.html The report "Capnography Equipment Market by Product (Multiparameter & Standalone Capnometer, Accessories), Technology (Mainstream, Sidestream, Microstream), Application (Cardiac Care, Trauma, Emergency Care), End User (Hospital) - Global Forecast to 2027" The global capnography equipment market is expected to reach USD 436 million by 2027 from an estimated USD 334 million in 2021, at a CAGR of 4.6% from 2022 to 2027. Market growth is mainly driven by the development of portable/POC capnography devices, clinical benefits of capnography equipment over pulse oximetry, and increasing number of surgeries. In addition, healthcare industry in emerging countries are expected to offer growth opportunities for players in the capnography equipment market. However, issues related to stringent (especially in the US) and ambiguous regulatory guidelines for the approval of capnography medical devices are expected to hinder the growth of the capnography equipment market during the forecast period. [more]
  • Healthcare_medical
  • Interventional Oncology Market worth $2.9 billion by 2026 https://www.marketsandmarkets.com/Market-Reports/interventional-oncology-market-203687164.html The report "Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires), Procedure (Thermal, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis), Enduser (Hospital, ASC) - Global Forecast to 2026" The global interventional oncology market size is estimated to be USD 1.9 billion in 2020 and is projected to reach USD 2.9 billion by 2026, at a CAGR of 6.8%. The increasing prevalence of diseases and disorders, technological advancements, and increased funding and public-private investments are the key factors driving the growth of the interventional oncology market. Medtronic (Ireland), Boston Scientific (US), BD (US), Terumo (Japan), Merit Medical (US), AngioDynamics (US), J&J (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), Interface Biomaterials BV (Netherlands), Guerbet (France), ABK Biomedical (Canada), Shape Memory Medical (US), Endo Shape (US), Monteris Medical (US), Instylla (US), Trisalus Lifesciences (US), Profound Medical Corp (Canada), Sirtex (US), Accuray (US), Baylis Medical (Canada), and ALPINION MEDICAL SYSTEMS (South Korea). The analysis of market developments between 2017 and 2020 revealed that several growth strategies such as research collaborations were adopted by market players to strengthen their product portfolios and maintain a competitive position in the human organoids market. [more]
  • Healthcare_medical
  • Airway Management Devices Market worth $2.5 billion by 2026 https://www.marketsandmarkets.com/Market-Reports/airway-management-device-market-116806061.html The report "Airway Management Devices Market by type (Endotracheal tubes, Tracheostomy tube, LMA, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Bougies), Application (Anesthesia, Emergency medicine), End user (Hospitals), COVID-19 Impact - Global Forecast to 2026" The airway management devices market is projected to reach USD 2.5 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 5.8% during the forecast period. Increasing prevalence of chronic respiratory diseases and respiratory tract infections have surged the demand for airway rescue among affected patients. As a result, the airway management devices market is witnessing a steady growth globally. Also, increasing admissions across emergency & intensive care units, favorable reimbursement coverage for airway management devices across developed countries, rise in geriatric population, growing investments in healthcare infrastructure, and high incidence of pre-term births are supporting the growth of the market. [more]
  • Healthcare_medical
  • Oligonucleotide Synthesis Market worth $14.1 billion by 2026 https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html The report "Oligonucleotide Synthesis Market by Product (Drug, Synthesized Oligos (Primer, Probe), Reagents), Type (Custom, Predesign), Application (Therapeutic (ASO, siRNA), Research (PCR), Diagnostic), End User (Hospital, Pharma, CROs) - Global Forecast to 2026", is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6% during the forecast period. The major factors driving the growth of this market include the increasing use of synthesized oligos in therapeutic applications, increasing government funding, and the growing focus on personalized medicine. [more]
  • Healthcare_medical
  • Protein Expression Market worth $5.4 billion by 2027 https://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html The report "Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region - Global Forecast to 2027", is expected to reach USD 5.4 billion by 2027 from an estimated USD 2.9 billion in 2022 at a CAGR of 13.3%. Factors such as the increasing incidence of chronic diseases, increasing research activities on recombinant-based protein expression, growth in the life sciences and biopharmaceutical industries, as well as the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market. [more]
  • Healthcare_medical
  • Point of Care Molecular Diagnostics Market worth $4.1 billion by 2026 https://bit.ly/3U7viUX The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Growth in the point-of-care molecular diagnostics industry is mainly driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. [more]
  • Healthcare_medical
  • Biosurgery Market worth $16.0 Billion by 2026 https://bit.ly/3DeKlW7 The report "Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) - Global Forecast to 2026" [more]
  • Healthcare_medical
  • Enteral Feeding Devices Market worth $4.9 billion by 2026 https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-device-market-183623035.html Enteral Feeding Devices Market by Type (Feeding Tube (Gastrostomy, Jejunostomy), Feeding Pump, Giving Set), Age Group (Adult, Pediatric), Application (Diabetes, Neurological Disorder, Cancer), End User (Hospital, ACS, Home Care) - Global Forecast to 2026 Fresenius Kabi holds the leading position in the enteral feeding devices market. The company provides innovative enteral feeding products. Fresenius is a multinational company that provides products and services for hospitals, dialysis centers, and outpatient medical care facilities. The company operates through four major business segments—Fresenius Medical Care, Fresenius Kabi, Fresenius Vamed, and Fresenius Helios. Fresenius Kabi is a subsidiary of Fresenius SE & Co. KGaA. The company specializes in infusion therapy products, intravenously administered drugs, medical devices, and clinical nutrition products that are used to treat critically ill patients. The company offers enteral feeding devices under its Clinical Nutrition and Medical Devices business segments. The company is expected to maintain its leading market position in the coming years owing to its strong product portfolio, geographic presence, and brand name in the global market. Its market leadership can also be attributed to its strong distribution and subsidiary network worldwide, enabling it to serve customers in North America, Europe, Latin America, Asia Pacific, and Africa. Fresenius Kabi operates in over 100 countries worldwide. [more]
  • Healthcare_medical
  • Eurofins Scientific (Luxembourg) and LabCorp (US) are the Key players in the Healthcare Analytical Testing Services Market https://www.marketsandmarkets.com/Market-Reports/healthcare-analytical-testing-services-market-108923833.html The global healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%. Growth in the market is driven by the growing focus towards the analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies and increasing acceptance of the QbD approach in pharma research/manufacturing. The healthcare analytical testing services market exhibited a dip in the year-on-year growth rate for the first half of 2020 since the COVID-19 outbreak resulted in decreased drug production in many countries. This impacted many segments of the analytical testing market, such as raw material testing and physical characterization services. However, there has been a solid recovery in the market from Q3 2020, fueled by growth in the pharmaceutical industry in response to the COVID-19 pandemic. In this report, the global healthcare analytical testing services market is segmented by type, end user, and region. [more]
  • Healthcare_medical
  • Alma Lasers (Isreal) and AbbVie Inc. (Ireland) are Leading Players in the Medical Aesthetics Market https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html The global medical aesthetics market is projected to reach USD 23.4 billion by 2027 from USD 13.9 billion in 2022, at a CAGR of 11.0% from 2022 to 2027. The market is expanding as a result of factors like the rising popularity of minimally invasive and noninvasive aesthetic procedures, the rising popularity of aesthetic procedures among geriatric patients, the accessibility of technologically advanced and user-friendly products, and the rising demand for aesthetic treatments among men. The availability and acceptance of alternative beauty and cosmetic goods, which are becoming more widely available, are, however, limiting the expansion of this market, as are the clinical risks and consequences connected with medical aesthetic operations. The medical aesthetics business is very competitive, with both established companies and newcomers competing for the same market share. As of 2021, the key players operating in the global medical aesthetics market are Advanced Energy Industries, Alma Lasers (Isreal), ANIKA THERAPEUTICS, INC. (US), AbbVie Inc. (Ireland), Cynosure (US), Cutera (California), and El.En. S.p.A.(Italy), Inmode Ltd.(Israel), Lumenis Be Ltd. (Israel), Fotona (US), Galderma (Switzerland), Johnson & Johnson Services, Inc(US), Merz Pharma (US), Medytox. (South Korea), Sientra, Inc.(US), Huadong Medicine Co., Ltd (China), Bausch Health Companies Inc.(Canada), Candela Corporation. (US), Venus Concept(Canada), aeroloase(US), Sciton.(US), and Bohus BioTech AB(US) among others. [more]
  • Healthcare_medical
  • Thermo Fisher Scientific Inc. (US) and Merck KGaA (Germany) are Leadig Players in the Protein Expression Market https://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html The protein expression market is expected to reach USD 5.4 million in 2027 from USD 2.9 million in 2022 at a CAGR of 13.3% during the forecast period. Factors such as growing pharmaceutical and biotechnology as well as life-sciences industries, a rise in the focus on recombinant-based protein expression, and the availability of investment for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market to a certain extent. [more]
  • Healthcare_medical
  • Home Healthcare Market 2022 Trend, Segmentation And Opportunities Forecast To 2026 https://bit.ly/3RL6EYF "Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2026", size is projected to reach USD 298.2 billion by 2026 from USD 198.9 billion in 2021, at a CAGR of 8.4% during the forecast period. [more]
  • Healthcare_medical
  • Medical Electrodes Market worth $2.1 billion by 2026 https://bit.ly/3SOWuav Medical Electrodes Market by Product [Diagnostic Electrodes (ECG, EEG, EMG), Therapeutic Electrodes (Defibrillator, Pacemaker)], Technology (Wet, Dry, Needle), Application (Neurophysiology, IOM), Usage (Disposable, Reusable), - Global Forecast to 2026 [more]
  • Healthcare_medical
  • Epigenetics Market worth $3.9 billion by 2027 https://bit.ly/3dINGEc The report "Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Software, Service), Method (DNA Methylation), Technique (NGS, PCR & qPCR), Application (Oncology, Immunology), End User - Global Forecast to 2027", was valued at USD 1.7 billion in 2022 and is expected to reach USD 3.9 billion by 2027 at a CAGR of 18.1% during the forecast period. [more]
  • Healthcare_medical
  • Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2027 https://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html [more]

0 following